Cargando…
A preliminary study of pamidronic acid downregulation of angiogenic factors IGF-1/PECAM-1 expression in circulating level in bone metastatic breast cancer patients
OBJECTIVE: To evaluate the expressions of circulating angiogenic factors affected by pamidronic acid (PA) intravenous infusion in bone metastatic breast cancer patients and the impact on their prognosis. METHODS: Peripheral blood of ten bone metastatic breast cancer patients was collected for serum...
Autores principales: | Wang, Zeng, Lei, Lei, Cai, Xin-jun, Chen, Ling Ya, Yuan, Meiqin, Yang, Guonong, Huang, Ping, Wang, Xiaojia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888719/ https://www.ncbi.nlm.nih.gov/pubmed/27307756 http://dx.doi.org/10.2147/OTT.S103624 |
Ejemplares similares
-
Osteoclast inhibition by pamidronate in metastatic prostate cancer: a preliminary study.
por: Clarke, N. W., et al.
Publicado: (1991) -
PECAM-1 senses the pressure
por: LeBrasseur, Nicole
Publicado: (2002) -
Influence of PECAM‐1 ligand interactions on PECAM‐1‐dependent cell motility and filopodia extension
por: Abraham, Valsamma, et al.
Publicado: (2016) -
High-dose intravenous pamidronate for metastatic bone pain.
por: Purohit, O. P., et al.
Publicado: (1994) -
Metabolic effects of pamidronate in patients with metastatic bone disease.
por: Vinholes, J., et al.
Publicado: (1996)